The Netherlands
Jenscare Scientific Co., Ltd. is a pioneering player in the Biotechnology and Health Care industries, established in 2011 and headquartered in China. With the slogan, "Dedicated to Developing High-quality Innovative Medical Devices for Unmet Clinical Needs," the company focuses on addressing gaps in structural heart disease intervention through independent innovation and research and development.
The firm’s comprehensive product portfolio is supported by numerous global patents and a production quality system that meets international standards. A key aspect of Jenscare's strategy is its commitment to globalization while being rooted in the Chinese market, aiming to benefit patients worldwide through its cutting-edge solutions.
In its last investment round on May 28, 2021, Jenscare secured funds from a diverse pool of investors including Forebright Capital, Primavera Capital, CICC, Cormorant Asset Management, and others. This backing underscores the confidence and interest from prominent investors in Jenscare's potential and growth trajectory.
